Franklin Resources Inc. Purchases Shares of 19,908 Astrana Health, Inc. (NASDAQ:ASTH)

Franklin Resources Inc. acquired a new position in Astrana Health, Inc. (NASDAQ:ASTH) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 19,908 shares of the company’s stock, valued at approximately $1,187,000.

Several other large investors have also bought and sold shares of the stock. GAMMA Investing LLC acquired a new stake in shares of Astrana Health in the third quarter valued at about $34,000. Nisa Investment Advisors LLC bought a new position in Astrana Health during the 3rd quarter worth approximately $35,000. KBC Group NV acquired a new position in shares of Astrana Health in the 3rd quarter worth approximately $70,000. Quarry LP bought a new stake in shares of Astrana Health in the 3rd quarter valued at $77,000. Finally, Quest Partners LLC acquired a new stake in shares of Astrana Health during the third quarter worth $133,000. 52.77% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. TD Cowen started coverage on shares of Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 price target on the stock. Macquarie raised shares of Astrana Health to a “hold” rating in a research report on Monday, December 16th. KeyCorp started coverage on shares of Astrana Health in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Robert W. Baird boosted their target price on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Finally, BTIG Research increased their price target on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a report on Thursday, October 3rd. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Astrana Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $65.17.

Astrana Health Trading Down 2.4 %

NASDAQ ASTH opened at $32.72 on Friday. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $1.84 billion, a P/E ratio of 25.17, a PEG ratio of 1.80 and a beta of 1.13. The business has a fifty day simple moving average of $44.45 and a 200 day simple moving average of $47.57. Astrana Health, Inc. has a 12 month low of $32.21 and a 12 month high of $63.20.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The company had revenue of $478.71 million for the quarter, compared to analyst estimates of $462.01 million. During the same period last year, the firm earned $0.47 earnings per share. On average, analysts predict that Astrana Health, Inc. will post 1.16 EPS for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.